Filing Details
- Accession Number:
- 0001104659-22-103166
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-27 08:45:28
- Reporting Period:
- 2022-09-23
- Accepted Time:
- 2022-09-27 08:45:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1875558 | Nuvectis Pharma Inc. | NVCT | Pharmaceutical Preparations (2834) | 862405608 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1896056 | Shay Shemesh | C/O Nuvectis Pharma, Inc. 1 Bridge Plaza, Suite 275 Fort Lee NJ 07024 | Chief Dev. & Ops. Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-23 | 220 | $7.87 | 1,245,065 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Includes 48,399 shares of restricted stock and 60,000 restricted stock units.